Tekla Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Tekla Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-109,246	Closed	-$1.97M	–	232
2020 Q2	$1.97M	Hold	109,246	–	–	0.07%	161
2020 Q1	$779K	Sell	109,246 -52,653	-33%	-$657K	0.04%	184
2019 Q4	$3.87M	Buy	161,899 +46,451	+40%	+$1.28M	0.15%	127
2019 Q3	$3.1M	Hold	115,448	–	–	0.14%	114
2019 Q2	$3.13M	Hold	115,448	–	–	0.13%	118
2019 Q1	$4.01M	Hold	115,448	–	–	0.16%	108
2018 Q4	$2.25M	Hold	115,448	–	–	0.1%	123
2018 Q3	$3.07M	Buy	115,448 +25,470	+28%	+$832K	0.11%	120
2018 Q2	$3.4M	Hold	89,978	–	–	0.13%	109
2018 Q1	$2.94M	Buy	+89,978	New	+$3.95M	0.11%	118

Tekla Capital Management's PTLA Position: Q3 2020 in Review

Tekla Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 109,246 shares — an estimated $1.97M sold.

Tekla Capital Management first reported a position in PTLA in Q1 2018 and held it in 10 quarters. The position peaked at $4.01M in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Tekla Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Tekla Capital Management sold 109,246 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.97M.
Tekla Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2018 and held it in 10 quarters.
Tekla Capital Management's Portola Pharmaceuticals, Inc. position peaked at $4.01M in Q1 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Tekla Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.